Rekord LOINC: 94327-4

Tylko wersja angielska ACTIVE

Powrót do listy LOINC
Szczegóły rekordu LOINC
Informacje podstawowe
Kod LOINC: 94327-4 FHIR
Long Common Name: PhenX - human papillomavirus vaccine use protocol 100802
Short Name: PhenX - HPV vaccine use protocol
Status: ACTIVE
Class Type: 2
Fully Specified Name (FSN)
EN Oryginalna wersja angielska
PhenX - human papillomavirus vaccine use protocol 100802 : - : Pt : ^Patient : - : PhenX
Klasyfikacja
Class:
ENPANEL.PHENX
Consumer Name: -
Order/Observation: Order
Panel Type: Panel
Informacje dodatkowe
Units Required: -
Example Units: -
UCUM Units: -
Version Last Changed: 2.68
Definicja i opis

The interviewer asks the individual whether s/he ever received a human papillomavirus (HPV) vaccination. If the response is yes, the interviewer asks about number of shots received. If the participant answers "yes" to question 1, the interviewer should complete the rest of the protocol. If the participant answers "no," then the protocol is deemed complete. The PhenX Working Group notes that GARDASIL® is also known internationally as Silgard. European Medicines Agency. (2009, September 25). Silgard European Public Assessment Report. Waknine, Y. (2006, October 2). International approvals: Singulair and Gardasil/Silgard. Medscape Today. Note: GARDASIL® by Merck & Co. is approved by the U.S. Food and Drug Administration (FDA) for use in females ages 9-26 and males ages 9-26. Note: CERVARIX® is manufactured by GlaxoSmithKline Biologicals and approved by the FDA for use in females ages 10-25.

Powiązane nazwy

Pan; Panel; PANEL.PHENX; Panl; PhenX - HPV vaccine use protocol; Pnl; Point in time; Random

Struktura panelu
Ładowanie...

Ładowanie struktury panelu...